Atlas Trials

Study Assessing Tolerability and Safety of AFFITOPE® PD03A in Patients With Early Parkinson's Disease

Clinical trial NCT02267434 · COMPLETED

Trial details

NCT number
NCT02267434
Sponsor
Affiris AG
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Parkinson DiseaseNeurodegenerative Diseases
Start date
2014-12-01
Primary completion
2016-08-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.